Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin for prophylaxis of sternal wound infections after median sternotomy
2007-004611-61Phase 4Completed
- Sponsor
- Medizinische Hochschule Hannover
- Start
- Oct 2007
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of daptomycin in surgical site infection (SSI) and sternal wound infection (2 arms), sponsored by Medizinische Hochschule Hannover. Primary endpoint: Incidence of sternal wound infections at day 30. Started Oct 2007; status: completed.
02
Drugs
daptomycin
03
Conditions
surgical site infection (SSI)sternal wound infection
Beyond the preview
Go deeper on 2007-004611-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004611-61.